Innovative technology has made an effective COVID-19 vaccine available at breakthrough speed. Now, Industry and Federal Government are gearing up to scale production capacity –– according to supply chain risk expert Exiger’s Brandon Daniels.

More from The Atlantic‘s Olga Khazan on why expediting the COVID-19 vaccine global supply chain is a complex endeavor:

Demo The
Exiger Platform

Save the Day
Be a supply chain superhero